MX2013009531A - Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden. - Google Patents

Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.

Info

Publication number
MX2013009531A
MX2013009531A MX2013009531A MX2013009531A MX2013009531A MX 2013009531 A MX2013009531 A MX 2013009531A MX 2013009531 A MX2013009531 A MX 2013009531A MX 2013009531 A MX2013009531 A MX 2013009531A MX 2013009531 A MX2013009531 A MX 2013009531A
Authority
MX
Mexico
Prior art keywords
compositions
stabilised
actives
same
preparing products
Prior art date
Application number
MX2013009531A
Other languages
English (en)
Other versions
MX359670B (es
Inventor
Sai Ying Ko
Original Assignee
Sai Ying Ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sai Ying Ko filed Critical Sai Ying Ko
Publication of MX2013009531A publication Critical patent/MX2013009531A/es
Publication of MX359670B publication Critical patent/MX359670B/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B01J13/043—Drying and spraying
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/02—Processes for applying liquids or other fluent materials performed by spraying

Abstract

La presente invención se relaciona ampliamente con un proceso para preparar productos que comprenden componentes activos y, en particular materiales biológicos, donde los componentes activos se estabilizan. La invención también se relaciona con composiciones que comprenden los productos y en particular, composiciones que comprenden materiales biológicos terapéuticos.
MX2013009531A 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden. MX359670B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AU2011/000173 WO2012109694A1 (en) 2011-02-18 2011-02-18 Process for preparing products comprising stabilised actives and compositions comprising same

Publications (2)

Publication Number Publication Date
MX2013009531A true MX2013009531A (es) 2014-03-26
MX359670B MX359670B (es) 2018-10-05

Family

ID=46671860

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013009531A MX359670B (es) 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX2018007514A MX2018007514A (es) 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018007514A MX2018007514A (es) 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.

Country Status (13)

Country Link
US (2) US8951566B2 (es)
EP (2) EP3381299B1 (es)
JP (1) JP5793578B2 (es)
KR (1) KR101796340B1 (es)
CN (1) CN102791151B (es)
AU (1) AU2011323059B2 (es)
BR (1) BR112013020841B8 (es)
CA (1) CA2827432C (es)
DK (1) DK2675301T3 (es)
ES (1) ES2832973T3 (es)
MX (2) MX359670B (es)
RU (1) RU2563685C2 (es)
WO (1) WO2012109694A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2675301T3 (en) * 2011-02-18 2019-03-25 Biolingus Ip Llc PROCEDURE FOR PRODUCING PRODUCTS CONTAINING STABILIZED ACTIVE SUBSTANCES
PE20151518A1 (es) 2012-11-13 2015-11-25 Gordagen Pharmaceuticals Pty Ltd Administracion transmucosa de tocotrienol
WO2015170286A2 (en) 2014-05-08 2015-11-12 Biolingus Ip Llc Modulation of blood glucose levels
CN104920339B (zh) * 2015-06-04 2017-11-03 天津大学 利用生物相容性颗粒保存细胞的方法
JP6169137B2 (ja) * 2015-08-07 2017-07-26 バイオリンガス アイピー エルエルシー 安定化された活性物質含有の生成物の調製方法、および同生成物含有の組成物
EP3368010A4 (en) * 2015-10-26 2019-04-10 Blaesi, Aron H. SOLID DOSAGE FOR IMMEDIATE ACTIVE COMPOSITION AND DEVICE AND METHOD FOR THE PRODUCTION THEREOF
EP3962455B1 (en) 2020-05-18 2022-08-31 Orexo AB New pharmaceutical composition for drug delivery
EP4236921A1 (en) 2021-11-25 2023-09-06 Orexo AB Pharmaceutical composition comprising adrenaline

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4949299B1 (es) * 1968-09-09 1974-12-26
DK125813B (da) * 1971-04-16 1973-05-07 Niro Atomizer As Apparat til tørring af fugtige pulvere.
KR900003941B1 (ko) * 1985-03-01 1990-06-05 프로인드 산교 가부시끼 가이샤 유동 조립-코팅 장치 및 방법
GB2177616B (en) * 1985-07-09 1988-07-06 Smidth & Co As F L Gas suspension reactor
SU1720678A1 (ru) 1990-05-17 1992-03-23 Рубежанский филиал Днепропетровского химико-технологического института им.Ф.Э.Дзержинского Массотеплообменный аппарат
US5601760A (en) * 1994-09-01 1997-02-11 The Regents Of The University Of California, A California Corporation Milk derived whey protein-based microencapsulating agents and a method of use
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
AUPR272901A0 (en) * 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
ES2235642B2 (es) 2003-12-18 2006-03-01 Gat Formulation Gmbh Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
US20060210614A1 (en) * 2003-12-26 2006-09-21 Nastech Pharmaceutical Company Inc. Method of treatment of a metabolic disease using intranasal administration of exendin peptide
GB2418382A (en) * 2004-09-24 2006-03-29 Mortimer Tech Holdings Particle treatment in an expanded toroidal bed reactor
EP2024076A1 (en) * 2006-05-22 2009-02-18 Nizo Food Research B.V. Protein encapsulated partocles
EP2217088A1 (en) * 2007-11-29 2010-08-18 NIZO Food Research B.V. Method for making protein-based encapsulates
WO2009080032A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising a systemically active small peptide
WO2009080024A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising an incretin mimetic
CN101844053B (zh) * 2010-05-10 2013-06-12 重庆佳玛机械制造有限公司 一种旋流式流化床包衣机
US9795576B2 (en) * 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
DK2675301T3 (en) * 2011-02-18 2019-03-25 Biolingus Ip Llc PROCEDURE FOR PRODUCING PRODUCTS CONTAINING STABILIZED ACTIVE SUBSTANCES

Also Published As

Publication number Publication date
EP2675301A4 (en) 2015-07-15
KR20140037822A (ko) 2014-03-27
US10369539B2 (en) 2019-08-06
DK2675301T3 (en) 2019-03-25
BR112013020841B1 (pt) 2021-10-26
EP2675301B1 (en) 2018-12-12
US8951566B2 (en) 2015-02-10
JP2014508750A (ja) 2014-04-10
CA2827432A1 (en) 2012-08-23
US20120219624A1 (en) 2012-08-30
CA2827432C (en) 2020-02-18
AU2011323059A1 (en) 2012-09-06
AU2011323059B2 (en) 2013-02-21
BR112013020841A2 (pt) 2016-08-02
RU2013140974A (ru) 2015-03-27
CN102791151B (zh) 2016-01-20
EP3381299A1 (en) 2018-10-03
EP2675301A1 (en) 2013-12-25
US20150342886A1 (en) 2015-12-03
EP3381299B1 (en) 2020-08-19
KR101796340B1 (ko) 2017-11-10
BR112013020841B8 (pt) 2021-11-30
MX359670B (es) 2018-10-05
RU2563685C2 (ru) 2015-09-20
MX2018007514A (es) 2022-10-21
CN102791151A (zh) 2012-11-21
ES2832973T3 (es) 2021-06-11
WO2012109694A1 (en) 2012-08-23
JP5793578B2 (ja) 2015-10-14

Similar Documents

Publication Publication Date Title
MX359670B (es) Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MD4589C1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
ZA201208198B (en) Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
IL230463A (en) Benzamides, their preparation and their pharmaceutical preparations
HUE037747T2 (hu) Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények
MX359288B (es) Forma iv del clorhidrato de ivabradina.
ZA201409367B (en) A method to produce a medicinal product comprising a biologically active protein and the resulting product
MX2014000829A (es) Particulas que comprenden un principio activo a base de poliacrilato.
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GB201114962D0 (en) Composition, process and product
HRP20160928T1 (hr) Farmaceutske kompozicije koje sadrže anakinra bez citrata
ZA201209674B (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
PL2729015T3 (pl) Aktywna formulacja do stosowania w produktach paszowych
MX346799B (es) Metodo para la produccion de oxindoles sustituidos en el n con sulfonilo.
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
EP2704570A4 (en) ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
GB201108343D0 (en) Honey composition
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
JO2857B1 (en) Vinyl pipers with modified activity of tumor-resistant TNF
MY169648A (en) Process for preparing products comprising stabilised actives and compositions comprising same
ZA201400802B (en) Active formulation for use in feed products

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BIOLINGUS IP LLC

FG Grant or registration